{
  "description": "FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)",
  "_filename": "CodeSystem-v2-0477.json",
  "package_name": "hl7.fhir.r3.examples",
  "date": null,
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablecodesystem" ]
  },
  "publisher": "HL7, Inc",
  "content": "complete",
  "name": "v2 Controlled Substance Schedule",
  "type": null,
  "experimental": "false",
  "resourceType": "CodeSystem",
  "title": null,
  "package_version": "3.0.2",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status",
    "valueString": "External"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger": 0
  } ],
  "status": "active",
  "id": "0411ef3e-8226-43e0-bb46-c8fee47540ef",
  "valueSet": "http://hl7.org/fhir/ValueSet/v2-0477",
  "kind": null,
  "url": "http://hl7.org/fhir/v2/0477",
  "identifier": {
    "value": "urn:oid:2.16.840.1.113883.18.304",
    "system": "urn:ietf:rfc:3986"
  },
  "concept": [ {
    "code": "I",
    "display": "Schedule I",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."
    } ]
  }, {
    "code": "II",
    "display": "Schedule II",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."
    } ]
  }, {
    "code": "III",
    "display": "Schedule III",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."
    } ]
  }, {
    "code": "IV",
    "display": "Schedule IV",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."
    } ]
  }, {
    "code": "V",
    "display": "Schedule V",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."
    } ]
  }, {
    "code": "VI",
    "display": "Schedule VI",
    "extension": [ {
      "url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
      "valueString": "State defined"
    } ]
  } ],
  "caseSensitive": false,
  "version": "2.8.2",
  "contact": [ {
    "telecom": [ {
      "value": "http://hl7.org",
      "system": "url"
    } ]
  } ]
}